Singapore markets close in 2 hours 52 minutes

TELA Bio, Inc. (TELA)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
5.98-0.14 (-2.29%)
At close: 04:00PM EDT
5.98 0.00 (0.00%)
After hours: 04:02PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 147.44M
Enterprise value 151.53M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)2.29
Price/book (mrq)10.25
Enterprise value/revenue 2.40
Enterprise value/EBITDA -5.01

Trading information

Stock price history

Beta (5Y monthly) 1.00
52-week change 3-44.63%
S&P500 52-week change 327.84%
52-week high 311.26
52-week low 34.24
50-day moving average 35.22
200-day moving average 36.49

Share statistics

Avg vol (3-month) 3164.44k
Avg vol (10-day) 3138.56k
Shares outstanding 524.66M
Implied shares outstanding 624.66M
Float 815.75M
% held by insiders 12.27%
% held by institutions 185.90%
Shares short (30 Apr 2024) 41.13M
Short ratio (30 Apr 2024) 46.11
Short % of float (30 Apr 2024) 47.78%
Short % of shares outstanding (30 Apr 2024) 44.57%
Shares short (prior month 28 Mar 2024) 4786.24k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin -63.82%
Operating margin (ttm)-74.72%

Management effectiveness

Return on assets (ttm)-43.28%
Return on equity (ttm)-459.89%

Income statement

Revenue (ttm)63.15M
Revenue per share (ttm)2.61
Quarterly revenue growth (yoy)39.40%
Gross profit (ttm)N/A
EBITDA -44.4M
Net income avi to common (ttm)-40.3M
Diluted EPS (ttm)-1.64
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)37.14M
Total cash per share (mrq)1.51
Total debt (mrq)42.84M
Total debt/equity (mrq)297.85%
Current ratio (mrq)4.12
Book value per share (mrq)0.58

Cash flow statement

Operating cash flow (ttm)-43.67M
Levered free cash flow (ttm)-28.1M